Squamous cell carcinoma of the lung. Clinicopathologic study

Area of Science:

• Oncology
• Pulmonology
• Cancer Research

Background:

• Squamous cell carcinoma (SCC) is a major subtype of non-small cell lung cancer.
• Understanding the diagnostic, therapeutic, and prognostic factors of lung SCC is crucial for improving patient outcomes.
• Limited effective treatment options exist for advanced lung SCC.

Purpose of the Study:

• To investigate the diagnostic features of lung squamous cell carcinoma.
• To evaluate the therapeutic efficacy of different treatment modalities for lung SCC.
• To determine the prognostic indicators for patients diagnosed with lung SCC.

Main Methods:

• Retrospective analysis of 734 patients diagnosed with squamous cell carcinoma of the lung.
• Evaluation of treatment outcomes including surgical excision, radiation therapy, and chemotherapy.
• Assessment of survival rates, including five-year survival and median survival.

Main Results:

• The overall five-year survival rate for lung SCC was 5%, with a median survival of 5.9 months.
• Surgical excision was an effective therapy for early-stage disease, achieving curative resections in 151 of 201 patients.
• Other therapeutic approaches, including combined radiation and chemotherapy, showed limited effectiveness, with one documented cure after 11 years and three months.

Conclusions:

• Early-stage squamous cell carcinoma of the lung is best treated with surgical excision for curative intent.
• Current non-surgical therapeutic options for lung SCC demonstrate limited efficacy.
• Further research into novel treatment strategies is warranted to improve survival rates for lung SCC patients.